PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsOpening A New Clinic
Pathology and Laboratory Medicine
Product Catalogue

​von Willebrand Concentrate/Coagulation Factor VIII

Transfusion Medicine

​Alternate Product Names
  • ​Humate P
  • Von Willebrand Factor Concentrate
  • Wilate
​Indications
  • ​Treatment and prevention of bleeding episodes in adult and pediatric patients in all types of congenital von Willebrand Disease
  • Treatment and prevention of bleeding episodes in adult patients with congenital factor VIII deficiency (Hemophilia A) 
​Resource Information

​Product Monographs:

Product Information:

Size/Volume Available
  • wilate® (Human von Willebrand Factor and Human Coagulation Factor VIII)
    • Volumes Available: 500 IU
  • Humate-P® (Antihemophilic Factor/von Willebrand factor Complex (Human))
    • Volumes Available: 1000 IU, 2000 IU
  • Products not listed may be available through Canadian Blood Services by contacting Transfusion Medicine or your site laboratory
Availability
​RUH​SCH​SPH​Rural
​Yes​No​No​Contact your site laboratory
  • ​SCH and SPH requests will be transported from RUH as requests are received
Pretransfusion Testing Requirements
  • ​None required
Forms Required

​Saskatoon:

Rural:

  • Contact your site laboratory

Home infusion program:

Ordering
  • Consultation with a Hematologist is recommended for dose determination
  • Specify type of coagulation concentrate and dosage required, based on clinical indication
  • Humate P® - Order by IU of von Willebrand Factor (vWF)
    • Ratio of vWF to FVIII is 2:1
  • wilate® - Order by IU of Factor VIII
    • Ratio of vWF to FVIII is 1:1
  • Off label requests for anyone other than bleeding disorders patients must be approved by the Transfusion Medicine Medical Physician
​Notes
​Administration

 

If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-56 v6

Last Modified: Tuesday, April 24, 2018 |
Questions or feedback about this page?